nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2026, 01, v.39 24-33
中国女性HIV感染者宫颈HPV感染现状的meta分析
基金项目(Foundation):
邮箱(Email): wiwdf@126.com;
DOI:
摘要:

目的 中国人类免疫缺陷病毒(human immunodeficiency virus, HIV)感染育龄期女性的宫颈癌防控尚未得到足够重视,宫颈癌筛查未纳入艾滋病抗病毒治疗门诊常规检查项目。本研究旨在通过Meta分析系统评价中国HIV感染育龄期女性的人乳头瘤病毒(human papilloma virus, HPV)感染及宫颈病变现状,为制定针对性宫颈癌筛查策略提供循证依据。方法 系统检索中国知网、万方、维普、Pubmed等数据库中关于中国HIV感染育龄期女性宫颈癌筛查的病例对照研究。提取并分析HIV感染女性(观察组)与HIV阴性女性(对照组)高危型HPV感染、低危型HPV感染、多重HPV感染、宫颈低度病变及宫颈高度病变的发病率。采用STATA 15.0软件进行统计分析,Begg's test检验评估发表偏倚。结果 共纳入16篇文献(中文14篇,英文2篇)。观察组高危型HPV感染、低危型HPV感染、多重HPV感染、宫颈低度病变及宫颈高度病变发病率分别为34.34%、14.20%、19.54%、14.00%及9.46%;对照组高危型HPV感染、低危型HPV感染、多重HPV感染、宫颈低度病变和宫颈高度病变发病率分别为17.42%、8.15%、5.24%、4.11%及2.64%。Meta分析显示:高危型HPV感染(OR=3.78,95%CI:2.36~3.36,P<0.05)、多重HPV感染和宫颈高度病变采用随机效应模型进行计算,95%置信区间分别为2.82(2.36~3.36)、3.78(1.99~7.18)和3.15(1.51~6.58),且统计学P值均<0.05,差异有统计学意义。低危型HPV感染采用随机效应模型进行计算,95%置信区间为1.62(0.97~2.69),但统计学P值>0.05,差异无统计学意义。宫颈低度病变选择固定效应进行分析,95%置信区间为2.94(2.05~4.22),差异无统计学意义(P=0.08)。结果显示,HIV感染可以明显增加中国女性的高危型HPV感染、多重HPV感染和宫颈高度病变的患病风险,HIV感染的中国女性的低危型HPV感染和宫颈低度病变的患病风险有升高趋势,但差异无统计学意义。结论 HIV感染可以明显增加中国女性的高危型HPV感染、多重HPV感染和宫颈高度病变的患病风险。

Abstract:

Objective Cervical cancer prevention and control among Chinese women of childbearing age infected with human immunodeficiency virus(HIV) have not received sufficient attention, and cervical cancer screening has not been incorporated into routine check-up items in HIV antiretroviral therapy clinics. This study aims to systematically evaluate the current status of human papillomavirus(HPV) infection and cervical lesions in Chinese HIV-infected women of childbearing age through meta-analysis, providing evidence-based data for developing targeted cervical cancer screening strategies. Methods Case-control studies on cervical cancer screening among Chinese HIV-infected women of childbearing age were systematically retrieved from databases such as CNKI, Wanfang, VIP, and PubMed. The incidence rates of high-risk HPV infection, low-risk HPV infection, multiple HPV infections, cervical low-grade lesions, and cervical high-grade lesions were extracted and analyzed for HIV-infected women(observation group) and HIV-negative women(control group). Statistical analysis was performed using STATA 15.0 software, and publication bias was assessed using Begg's test. Results A total of 16 articles(14 in Chinese and 2 in English) were included. The incidence rates of high-risk HPV infection, low-risk HPV infection, multiple HPV infections, cervical low-grade lesions, and cervical high-grade lesions in the observation group were 34.34%, 14.20%, 19.54%, 14.00%, and 9.46%, respectively. In the control group, the incidence rates were 17.42%, 8.15%, 5.24%, 4.11%, and 2.64%, respectively. Meta-analysis showed that high-risk HPV infection(OR=3.78, 95% CI: 2.36–3.36, P<0.05), multiple HPV infections, and cervical high-grade lesions were calculated using a random-effects model, with 95% confidence intervals of 2.82(2.36–3.36), 3.78(1.99–7.18), and 3.15(1.51–6.58), respectively, and the statistical P-values were all < 0.05, indicating significant differences. Low-risk HPV infection was calculated using a random-effects model, with a 95% confidence interval of 1.62(0.97–2.69), but the statistical P-value was > 0.05, indicating no significant difference. Cervical low-grade lesions were analyzed using a fixed-effects model, with a 95% confidence interval of 2.94(2.05–4.22), and the difference was not statistically significant(P=0.08). The results indicate that HIV infection can significantly increase the risk of high-risk HPV infection, multiple HPV infections, and cervical high-grade lesions in Chinese women. Although the risk of low-risk HPV infection and cervical low-grade lesions appears elevated in HIV-infected Chinese women, the differences are not statistically significant. Conclusion HIV infection can significantly increase the risk of high-risk HPV infection, multiple HPV infections, and cervical high-grade lesions in Chinese women.

参考文献

[1]孔北华,马丁,段涛.妇产科学[M].10版.北京:人民卫生出版社,2024:214.

[2]陈娟娟,蔡少航,陆艾丽.艾滋病定义性肿瘤诊疗专家共识[J].中国艾滋病性病,2025,31(6):579-598. DOI:10.13419/j. cnki.aids.2025.06.01.

[3]曹立娟,张建波,况轶群,等. HIV/AIDS患者宫颈HPV感染临床研究[J].皮肤病与性病,2025,47(1):6-10. DOI:10.3969/j.issn.1002-1310.2025.01.001.

[4]中国抗癌协会宫颈癌专业委员会.子宫颈癌筛查规范(2025年版)[J].中国实用妇科与产科杂志,2025,41(3):332-337. DOI:10.19538/j.fk2025030115.

[5]罗琳琳,姜琦,胡新宁,等.艾滋病合并恶性肿瘤研究进展[J].中华医院感染学杂志,2024,34(17):2715-2720. DOI:10.11816/cn.ni.2024-240130.

[6]Peterson J, Welch V, Losos M,&Tugwell, P. The Newcastle-Ottawa Scale(NOS)for assessing the quality of nonrandomized studies in meta-analysis[EB/OL].[2025-05-11]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.

[7]Chen MJ, Wu MY, Yang JH, et al. Increased frequency of genital human papillomavirus infection in human immunodeficiency virus-seropositive Taiwanese women[J]. J Formos Med Assoc, 2005, 104(1):34-38.

[8]温贵华,刘晋洪,黄玲,等.深圳市HIV阳性人群HPV病毒载量分析[J].中国公共卫生,2009,25(7):795-796. DOI:10.3321/j.issn:1001-0580.2009.07.011.

[9]郭晓峰,李晶,何浩岚,等. HIV/AIDS病人与高危型人乳头瘤病毒感染的相关性研究[J].中国艾滋病性病,2010,16(5):492-494.DOI:10.13419/j.cnki.aids.2010.05.029.

[10]Zhang YX, Xiong Y, Gui XE, et al. Epidemiologic risk profile of human papillomavirus infections in human immunodeficiency virus-positive Chinese women[J]. Jpn J Infect Dis, 2011, 64(5):411-416.

[11]郭晓峰,李晶,戴卫东. HIV/AIDS与人乳头瘤病毒感染及宫颈病变的相关性研究[J].现代妇产科进展,2013,22(7):565-567. DOI:10.13283/j.cnki.xdfckjz.2013.07.016.

[12]罗丽丽,陈淑慧,熊艳,等. HIV阳性女性患者P16INK4a蛋白表达与HPV感染相关性分析[J].肿瘤学杂志,2013,19(8):600-604.

[13]谢小平,唐双阳,刘安元,等.衡阳地区HIV阳性妇女宫颈HPV感染情况研究[J].肿瘤药学,2013,3(3):188-191. DOI:10.3969/j.issn.2095-1264.2013.045.

[14]胡玉红,易为,伊诺,等. HIV阳性妇女感染高危型人乳头瘤病毒的临床研究[J].中国妇产科临床杂志,2015,16(5):438-439. DOI:10.13390/j.issn.1672-1861.2015.05.017.

[15]蔡秋娥,万建玉,王淼,等. HIV阳性女性宫颈HR-HPV感染及子宫颈细胞学筛查[J].中国热带医学,2017,17(9):939-940+958.DOI:10.13604/j.cnki.46-1064/r.2017.09.23.

[16]楼俊晓,符孜牧.女性人类免疫缺陷病毒感染与宫颈人乳头瘤状病毒感染的相关性分析[J].中国妇幼保健,2017,32(7):1396-1399. DOI:10.7620/zgfybj.j.issn.1001-4411.2017.07.14.

[17]万建玉,蔡秋娥,陈丽云,等.女性感染HIV与宫颈HR-HPV感染的相关性分析[J].实用临床医学,2017,18(7):48-50. DOI:10.13764/j.cnki.lcsy.2017.07.019.

[18]周新刚,李慢,滕晓英,等.无症状人类免疫缺陷病毒女性携带者子宫颈人乳头瘤病毒感染状况分析[J].中国妇产科临床杂志,2017,18(4):309-312. DOI:10.13390/j.issn.1672-1861.2017.04.006.

[19]袁会英,王烨. HIV/AIDS病人与高危型人乳头瘤病毒感染的关系[J].实用妇科内分泌杂志(电子版),2017,4(29):84-85+88. DOI:10.16484/j.cnki.issn2095-8803.2017.29.055.

[20]李英伟,庞俊,潘莲花,等. HIV/AIDS妇女宫颈癌筛查结果分析[J].广西医学,2018,40(16):1875-1876. DOI:10.11675/j.issn.0253-4304.2018.16.27.

[21]赵海燕. HIV阳性女性宫颈HR-HPV感染及子宫颈细胞学筛查研究[J].中外医疗,2018,37(23):27-29. DOI:10.16662/j.cnki.1674-0742.2018.23.027.

[22]万建玉,蔡秋娥,王淼,等.深圳地区女性HIV合并宫颈HPV感染现状调查及临床干预的相关性研究[J].中国性科学,2020,29(3):27-31. DOI:10.3969/j.issn.1672-1993.2020.03.009.

[23]Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018:a worldwide analysis[J].Lancet Glob Health, 2020, 8(2):e191-e203. DOI:10.1016/S2214-109X(19)30482-6.

[24]Singini MG, Singh E, Bradshaw D, et al. HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women[J]. Infect Agent Cancer,2022, 17(1):14. DOI:10.1186/s13027-022-00418-2.

[25]Harlfinger J, Sommer I, Gartlehner G.[WHO Guideline for Screening and Treatment of Cervical Pre-Cancerous Lesions for Cervical Cancer Prevention(Second Edition)][J]. Gesundheitswesen, 2023,85(7):630-634. German. DOI:10.1055/a-2052-6652.

[26]沈银忠.中国艾滋病诊疗指南(2024版)[J].中国病毒病杂志,2025,15(1):4-32. DOI:10.16505/j.2095-0136.2025.0001.

[27]Ambrosioni J, Levi L, Alagaratnam J, et al. Major revision version12.0 of the European AIDS Clinical Society guidelines 2023[J]. HIV Med, 2023, 24(11):1126-1136. DOI:10.1111/hiv.13542.

[28]Reid E, Suneja G, Ambinder RF, et al. Cancer in people living with HIV, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2018, 16(8):986-1017. DOI:10.6004/jnccn.2018.0066.

[29]Castle PE, Einstein MH, Sahasrabuddhe VV. Cervical cancer prevention and control in women living with human immunodeficiency virus[J]. CA Cancer J Clin, 2021, 71(6):505-526. DOI:10.3322/caac.21696.

基本信息:

中图分类号:R737.33;R512.91

引用信息:

[1]姚娟娟,王夫川,易为.中国女性HIV感染者宫颈HPV感染现状的meta分析[J].传染病信息,2026,39(01):24-33.

发布时间:

2026-02-28

出版时间:

2026-02-28

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文